Shopping Cart

Remove All
Your shopping cart is currently empty

Filter

Applied FilterClear all

By Target

Antiviral
(1)
Others
(6)

Filter

Search Result

Results for "

sars-cov-2 nsp13-in-2

" in TargetMol Product Catalog

Inhibitors & Agonists
7
Recombinant Protein
1

SARS-CoV-2 nsp13-IN-2

T62264522660-61-3

SARS-CoV-2 nsp13-IN-2 (Compound C2) is a small molecule inhibitor targeting the SARS-CoV-2 non-structural protein 13 (nsp13), specifically acting on the nsp13 ssDNA+ATPase with an IC50 of 42 μM.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2 nsp13-IN-4

T62031923140-39-0

SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective small-molecule inhibitor of nsp13 helicase, inhibiting the ssDNA+ ATPase activity of nsp13 with an IC50 of 57 μM, and providing a broad-spectrum antiviral effect.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2 nsp13-IN-6

T62248951588-85-5

SARS-CoV-2 nsp13-IN-6 (compound C5) is a potent inhibitor of the SARS-CoV-2 non-structural protein 13 (nsp13), targeting ssDNA+ATPase (IC50: 27 μM) and ssDNA-ATPase (IC50: 33 μM). nsp13-IN-6 can be utilized in anti-COVID-19 research.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2 nsp13-IN-3

T623751015582-31-6

SARS-CoV-2 nsp13-IN-3 (Compound C3) is a small molecule inhibitor of SARS-CoV-2 non-structural protein 13 (nsp13), targeting nsp13 ssDNA+ATPase with an IC50 of 32 μM.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2 nsp13-IN-1

T624131005304-44-8

SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent inhibitor of nsp13 (non-structural protein 13), selectively inhibiting nsp13 ssDNA+ATPase with an IC50 of 6 μM, but not ssDNA-ATPase, and can be used to study COVID-19.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2 nsp13-IN-5

T63615912799-11-2

SARS-CoV-2 nsp13-IN-5 is a potent inhibitor of SARS-CoV-2 nsp13, effective on ssDNA+ATPase (IC50: 50 μM) and ssDNA-ATPase (IC50: 55 μM). It is applicable in anti-COVID-19 studies.

Inquiry Price

6-8 weeks

Size

QTY

SARS-CoV-2-IN-19

T639502244991-17-9

SARS-CoV-2-IN-19 is a potent inhibitor of SARS-CoV-2 (EC50: 8.8 μM). SARS-CoV-2-IN-19 is effective against SARS-CoV-2 decapping enzyme (nsp13), a highly conserved enzyme that exhibits potential against emerging HCoV outbreaks. SARS-CoV-2-IN-19 exhibits research potential for infectious diseases.

Inquiry Price

6-8 weeks

Size

QTY

Go to page 1

Page of 1

Product Comparison

Product
Bioactive
Species
Expression System
Tag
Accession Number
Amino Acid
Construction
Molecular Weight
Endotoxin
Formulation
Reconstitution
Stability & Storage
Shipping
Research Background
Size